基础胰岛素治疗失效后的治疗选择被引量：1

The selection in type 2 diabetes of treatment failure with Basal Insulin

下载PDF

导出

摘要 2型糖尿病是一种进行性疾病,随着β细胞功能不断下降,患者胰岛素早相分泌缺失,进而造成餐后血糖升高。餐后血糖升高增加糖尿病并发症风险,因此,在治疗方案调整时,要更加关注对餐后血糖的控制,安全有效控制血糖。在可覆盖餐时胰岛素的方案中,门冬胰岛素30是兼顾疗效、安全、方便和经济性的选择。临床研究显示,基础胰岛素治疗失效后,换用门冬胰岛素有效,且更加安全,患者依从性也更好。

作者龚玉萍母义明

机构地区江西省萍乡市人民医院内分泌科解放军总医院内分泌科

出处《药品评价》 CAS 2015年第21期10-12,29,共4页 Drug Evaluation

关键词 2型糖尿病基础胰岛素治疗失效门冬胰岛素30

分类号 R587.1 [医药卫生—内分泌]

引文网络
相关文献

参考文献4

1高妍,郭晓蕙,段文若,罗涌,胡茂清,孙丽荣,王立,卜瑞芳,洪天配,徐焱成,张木勋,刘俊江,包玉倩.双时相门冬胰岛素30联合二甲双胍治疗基础胰岛素控制不佳的2型糖尿病患者：疗效及安全性评价[J].中华内分泌代谢杂志,2010,26(12):1019-1022. 被引量：31
2Chen Liming,Xing Xiaoyan,Lei Minxiang,Liu Jie,Shi Yongquan,Li Pengqiu,Qin Guijun,Li Chengjiang,Li Yukun,Wang Qing,Gao Tianshu,Hu Ling,Wang Yangwei,Yang Wenying.Biphasic insulin aspart 30 improved glycemic control in Chinese patients with type 2 diabetes poorly controlled on oral glucose-lowering drugs： a subgroup analysis of the A1chieve study[J].Chinese Medical Journal,2014(2):208-212. 被引量：20
3PANG Can BAO Yu-qian WANG Chen LU Jun-xi JIA Wei-ping XIANG Kun-san.Relationship between the level of fasting plasma glucose and beta cell functions in Chinese with or without diabetes[J].Chinese Medical Journal,2008(21):2119-2123. 被引量：35
4中华医学会糖尿病学分会.中国2型糖尿病防治指南（2013年版）[J].中国糖尿病杂志,2014,22(8). 被引量：6722

二级参考文献8

1Brunton S.Insulin regimens for type 2 diabetes mellitus.J Fam Pract,2006,55:S10-S17.
2International Diabetes Federation.Global Guidelines for Type 2 Diabetes,2005.
3Davidson JA,Blonde L,Jellinger PS,et al.Road Map for the prevention and treatment of type 2 diabetes.Endocr Pract,2006,12 (Suppl 1):148.
4AACE/ACE Glycemic Control algorithm consensus panel.Consensus Panel on Type 2 Diabetes Mellitus:An Algorithm for Glycemic Control Endocr Pract.2009,15:541.
5UK Prospective Diabetes Study Group:Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).Lancet,1998,352:837.
6Raskin PR,Hollander PA,Lewin A,et al.Basal insulin or premix analogue therapy in type 2 diabetes patients.Eur J Intern Med.2007,18:56-62.
7Woerle HJ,Szoke E,Meyer C,et al.Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes.Am J Physiol Endocrinol Metab,290:E67-E77.
8The Diabetes Control and Complications Trial (DCCT) Research Group.The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.Diabetes,1995,44:968-983.